TerraPower Isotopes Collaborates with Oncidium Foundation to Donate Actinium-225, Expanding Cancer T

[Marlin]

TerraPower Isotopes Collaborates with Oncidium Foundation to Donate Actinium-225, Expanding Cancer Treatment Access

https://www.terrapower.com/TerraPower-Isotopes-Collaborates-With-Oncidium-Foundation-to-Donate-Actinium-225

[Core Content]

TerraPower Isotopes has partnered with the Oncidium Foundation to donate actinium-225 for use in targeted radionuclide therapy. This collaboration integrates the company into a global supply network designed to provide cancer treatments to patients in financial need. The initiative utilizes the company's existing weekly production and logistics channels to expand access to experimental alpha therapies currently undergoing clinical trials.

TerraPower Isotopes Collaborates with Oncidium Foundation to Donate Actinium-225

BELLEVUE, WA – July 29, 2026 – TerraPower Isotopes (TPI), an affiliate of TerraPower, a nuclear innovation company, today announced its commitment to donate actinium-2251 (Ac-225) coordinated through the Oncidium foundation.

The Oncidium foundation, a non-profit dedicated to advancing global access to targeted radionuclide therapy for cancer care, established the RLT-Connect program to deliver this therapy to patients in financial need, ensuring that everyone has an equal opportunity to access potentially life-changing treatment, wherever and whoever they are. The donation marks TPI's entry into Oncidium's ecosystem of radioisotope suppliers, healthcare practitioners and radiopharmacies working together to close...

Read the full article at terrapower.com:
https://www.terrapower.com/TerraPower-Isotopes-Collaborates-With-Oncidium-Foundation-to-Donate-Actinium-225